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CELL MEDIATED IMMUNE RE-
ACTIONS AGAINST RAT TUMOUR
CELLS DETECTED BY IN VITRO
MICROCYTOTOXICITY ASSAYS. M.
ZOLLER, A. M. DICKINSON and M. J. EMBLE-
TON, Cancer Research CampaignLaboratories,
University of Nottingham.
Rats immune to one of 6 syngeneic
tumours with individually distinct tumour
associated rejection antigens, or rats bearing
growing tumours were tested for cell mediated
immunity to their own or other tumours in
comparison with normal control rats using a
microcytotoxicity assay. Lymph node cells
(LNC) were tested at ratios of2000, 1000, 500
and 250 per tumour target cell. In most
cases LNC from immune rats were cytotoxic
specifically for the immunizing tumour with
little cross-reactivity at high LNC ratios,
although specific cytotoxicity was diminished
at low ratios. LNC from 3-16 day tumour
bearers were completely cross-reactive at
high ratios but showed some tumour specifi-
city at low ratios. The cross-reactivity at
high ratios disappeared later in tumour
growth, at a stage where tumour-specific
reactivity was still detectable. The results
indicate that rat,s of different immune status
may have lymphoid cells reactive against
antigens with different specificities or other
(nonspecific) effector cells at various ratios,
and these findings are relevant to the recent
controversy on the use of microcytotoxicity
tests for detecting immune reactions against
human tumours.
SEPARATION OF SUBPOPULATIONS
OF RAT LYMPH NODE CELLS CYTO-
TOXIC FOR TUMOUR TARGET
CELLS AND CAPABLE OF INHIBIT-
ING CYTOTOXICITY IN VITRO. R. C.
REES and J. BRAY, Cancer Research Cam-
paign Laboratories, University of Notting-
ham.
Chemically induced rat hepatomata and
sarcomata cells express both a tumour
specific and embryonic antigen at the cell
surface. Cell mediated immune responses
towards these antigens can be demonstrated
in tumour immune and tumour bearer rats.
In addition, multiparous pregnant rats show
reactivity towards the embryonic component,
and can be demonstrated by in vitro lympho-
cytoxicity tests. The nature of cytotoxic
effector cells from rats sensitized against both
antigen components has been studied by cell
fractionation on nylon wool columns. Cyto-
toxicity towards tumour associated embry-
onic antigen(s) is associated with fractions
enriched with Ig bearing lymphocytes, and is
separable from the cellular response directed
toward3 the tumour specific antigen.
Treatment of cytotoxic lymph node
preparations with carbonyl iron removes
cellular reactivity towards the embryonic but
not tumour specific antigen. In addition, a
subpopulation of mainly T lymphocytes,
isolated from multiparous pregnant rats, has
been isolated and shown to be capable of
abrogating cytotoxicity towards tumour cell
targets. Such cells may be important in
relation to preventing tumour rejection in
vivo, and the results are discussed in this
context.
BIOCHEMICAL IDENTIFICATION OF
A PROTEIN ASSOCIATED WITH RAT
TUMOUR AND EMBRYO CELL MEM-
BRANES. M. R. PRICE, Cancer Research
Campaign Laboratories, University of
Nottingham and R. W. STODDART, Strange-
ways Laboratory, Cambridge.
Plasma membrane fractions from trans-
planted 4-dimethylaminoazobenzene induced
rat hepatomata and spontaneously arising rat
mammary carcinomata were isolated from
tumour homogenates by sucrose density
gradient centrifugation in a zonal rotor.
Membrane fractions were also prepared
from normal tissues (liver, lung, kidney,
spleen) as well as from rat embryos. These
preparations were dissociated in the presence
of non-ionic detergents and membrane pro-
teins were analysed by isoelectric focusing in
polyacrylamide gels. A unique protein com-
ponent (pl 4 00 ± 0 05) was identified, this
being common to all tumour membrane
preparations and also to foetal membranes
obtained at a specific stage of embryogenesis.
It was not possible to demonstrate the
presence of this component in any of the
normal tissues examined. These findings areABSTRACTS OF MEMBERS PAPERS 241
discussed in relation to the occurrence and
expression of cross-reacting embryonic anti-
gens associated with the cell surface of these
rat tumours.
B AND T CELLS IN CANINE LYMPHO-
SARCOMA. D. E. ONIoNs, Department of
Clinical Veterinary Medicine, University of
Cambridge.
Canine multicentric lymphosarcoma is a
common spontaneous neoplasm of dogs.
Canine lymphoma cells, like normal canine
lymphocytes, may be divided into two classes,
T and B, based on the spontaneous rosette
formation between canine T cells and human
erythrocytes, and the presence of a receptor
for (human) complement on the surface of B
cells.
The presence of an Fc receptor on canine
lymphocytes appears to be an unreliable
marker for B cells as many complement
receptor lymphocytes (EACL) lack a
detectable Fc receptor for using a rosetting
technique with antibody coated eryth-
rocytes.
SCANNING ELECTRON MICROS-
COPY OF K CELL ACTIVITY ON RED
CELL MONOLAYERS. A. E. WILLIAMS,
Western General Hospital, Edinburgh, J. R.
INGLIS, W. J. Penhale, A. FARMER and W. J.
IRVINE, Department of Therapeutics, Uni-
versity of Edinburgh.
K cell activity against syngeneic cells
(De Landazuriet et al., Cell Immunol. 1974,
14, 193) and defects in K cell activity in
cancer patients (Wisloff et al., Scand. J.
Immunol., 1973, 2, 325) have been demon-
strated. However, the identity of the K cell
is still uncertain and conflicting evidence
supports B lymphocytes, monocytes, macro-
phages and other leucocytes.
We have used the SEM to examine the
interaction between human leucocytes
(separated in Ficoll-Triosil and pre-incubated
on glass) and antibody coated sheep erythro-
cyte monolayers (Kennedy and Axelrad,
Immunology, 1971, 20, 253). Only a small
proportion of the leucocyte suspension
adhered to the monolayer and the non-
adherent cells lacked antibody dependent
cytotoxic activity. Three morphologically
distinct cell types were associated with areas
of lysis in the erythrocyte monolayer within
4 h and correlation with light microscopy
suggested that they were macrophages,
granulocytes and lymphoid cells. Surface
changes in the erythrocytes during contact
with K cells indicate that mechanical factors
may be involved in cell lysis in this system.
THERAPY OF METHYL CHOLAN-
THRENE INDUCED CBA MOUSE TU-
MOURS WITH CORYNEBACTERIUM
PARVUM AND IRRADIATED TU-
MOUR CELLS. R. BOMFORD, Depart-
ment of Experimental Immunobiology,
WellcomeResearchLaboratories,Beckenham.
Mice were injected subcutaneously with
2 x 104 tumour cells and 2 days later given
C. parvum, irradiated tumour cells, or both
admixed, into the footpad. Tumour growth
was unaffected by C. parvum or tumour cells
alone, but was suppressed by appropriate
mixtures. The conditions for successful
therapy were: 1. sufficient tumour cells
(> 5 x 104); 2. sufficient, but not excessive,
C. parvum (optimally between about 5 to
20 [kg, increasing with the dose of tumour
cells); 3. the same tumour cells in the tumour
challenge and treatment mixture; other
MCA tumour cells were ineffective; 4. mice
with an intact T cell system; tumour growth
was not suppressed in T cell depleted mice.
The results suggest that the therapeutic
effect depends on the potentiation by C.
parvum of a T cell dependent component of
the immune response to TSTAs.
ROLE OF IMMUNOCOMPETENCE IN
LOCALIZED BCG SUPPRESSION OF
TUMOUR GROWTH. M. V. PIMM and
D. G. Hopper, Cancer Research Campaign
Laboratories, University ofNottingham.
Admixture ofBCG organisms with cells of
syngeneically transplanted rat tumours pre-
vents their development and this leads to
immunologically specific rejection of tumour
deposits at distant sites. Immunosuppres-
sion by whole body irradiation did not pre-
vent suppression ofgrowth from mixed BCG:
tumour cell inocula but did abrogate the
concomitant rejection of distant challenge
inocula. Tumour suppression at the site of
BCG was, however, prevented by macrophage
depletion of the host by silica treatment.
These observations suggest that local BCG
suppression of tumour does not require
lymphocyte mediated immune responses and
probably depends on less specific macrophage
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